Medelis WCCT Global

Cypress, United States Founded: 1998 • Age: 28 yrs Acquired By Altasciences
Full-service CRO expertise in influenza and oncology research is offered.
Request Access

About Medelis WCCT Global

Medelis WCCT Global is a company based in Cypress (United States) founded in 1998 was acquired by Altasciences in February 2021.. Medelis WCCT Global has raised $17 million across 2 funding rounds from investors including Altasciences, Medivate Partners and Housatonic Partners. Medelis WCCT Global has completed 1 acquisition, including Medelis. Medelis WCCT Global operates in a competitive market with competitors including Celgene, Syneos Health, Emmes, Parexel and PRA Health Sciences, among others.

  • Headquarter Cypress, United States
  • Sectors
    Healthcare
  • Email
    ***********
  • Phone
    *********
  • Website
    *********
  • Social
    *********
  • Legal Name Wcct Global, Inc.
Operational Areas
Healthcare → Healthcare Services & Infrastructure
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Total Equity Funding
    $17 M (USD)

    in 2 rounds

  • Latest Funding Round
    $17 M (USD), Private Equity Round

    Jun 26, 2015

  • Investors
  • Employee Count
    Employee Count
  • Investments & Acquisitions
  • Acquired by
    Altasciences

    (Feb 19, 2021)

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal
People of Medelis WCCT Global
Headcount 200-500
Employee Profiles 16
Employee Profiles
People
Bonnie B.
Physician Investigator
People
Meihui Li
Clinical Research Coordinator
People
Jon Rojas
Chief Operating Officer
People
Zaid Alamiri
Research Asst

Unlock access to complete

Funding Insights of Medelis WCCT Global

Medelis WCCT Global has successfully raised a total of $17M across 2 strategic funding rounds. The most recent funding activity was a Private Equity Round round of $17 million completed in June 2015. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding
  • Total Rounds 2
  • Last Round Private Equity Round — $17.0M
  • First Round
  • Investors Count 2
Date Amount Transaction Name Valuation Lead Investors Investors
Jun, 2015 Amount Private Equity Round - Medelis WCCT Global Valuation Medivate Partners
Jan, 2012 Amount Private Equity Round - Medelis WCCT Global Valuation

investors

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in Medelis WCCT Global

Medelis WCCT Global has secured backing from 3 investors, including venture fund investors. Prominent investors backing the company include Altasciences, Medivate Partners and Housatonic Partners. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Venture Fund
Investor Description Founded Year Domain Location
-
Founded Year Domain Location
Housatonic Partners is engaged in private equity investments.
Founded Year Domain Location
Early phase clinical research services are provided in North America.
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by Medelis WCCT Global

Medelis WCCT Global has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Medelis. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Acquisitions
Company Name Description Domain Location Founded Year Amount
Oncology drug development services are offered by Medelis CRO.
2003
Company Name Description Domain Location Founded Year Amount
OVO is recognized as a smart digital payment application.
2017
Bionic investment advisor platform
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014

Financial Statements - Medelis WCCT Global

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Medelis Wcct Global Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Medelis WCCT Global

Medelis WCCT Global operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Celgene, Syneos Health, Emmes, Parexel and PRA Health Sciences, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Therapies for cancer and inflammatory diseases are developed.
domain founded_year HQ Location
CRO clinical development services are provided by Syneos Health.
domain founded_year HQ Location
Outsourced contract research organization services are provided to clients.
domain founded_year HQ Location
Full-service clinical research organization services are provided globally by Parexel.
domain founded_year HQ Location
Global full-service CRO services are delivered in over 80 countries.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Medelis Wcct Global

Frequently Asked Questions about Medelis WCCT Global

When was Medelis WCCT Global founded?

Medelis WCCT Global was founded in 1998 and raised its 1st funding round 14 years after it was founded.

Where is Medelis WCCT Global located?

Medelis WCCT Global is headquartered in Cypress, United States. It is registered at Cypress, California, United States.

Is Medelis WCCT Global a funded company?

Medelis WCCT Global is a funded company, having raised a total of $17M across 2 funding rounds to date.

What does Medelis WCCT Global do?

Medelis, WCCT Global, formed by the merger of WCCT global (a specialized CRO) and Medelis (a speciality oncology CRO) is a full-service CRO with clinical pharmacology units for all phases of clinical research. Services offered include clinical data management, medical writing, monitoring, biostatistics, pharmacovigilance, clinical research site services, and clinical trial patient recruitment. Therapeutic areas covered include CNS, cardiovascular, glaucoma, hepatitis C, immunology, infectious disease, oncology, ophthalmology, paediatrics, and respiratory diseases. WCCT global company claims to be the first US CRO capable of conducting Flu Challenge trials. WCCT Global also claims that they have expertise in the development of antiviral drugs and vaccines for the treatment of a number of respiratory and enteric viral infections. Apart from Phase I to IV trials, the company is also capable of offering its services for cardiac safety testing, Cerebral Spinal Fluid (CSF) sampling, Biomarkers (FACS, platelet aggregometry, bronchoscopy, spirometry).Medelis is a speciality oncology CRO which was offering integrated services for oncology trials right from preclinical stage to phase 4 clinical trials, including immunotherapy services.

Who are the top competitors of Medelis WCCT Global?

Medelis WCCT Global's top competitors include Emmes, Syneos Health and ClinChoice.

How many acquisitions has Medelis WCCT Global made?

Medelis WCCT Global has made 1 acquisition, including Medelis.

Who are Medelis WCCT Global's investors?

Medelis WCCT Global has 3 investors. Key investors include Altasciences, Medivate Partners, and Housatonic Partners.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available